Insider Trading activities of Valera Pharmaceuticals Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Valera Pharmaceuticals Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Valera Pharmaceuticals Inc since year 2005. Table 2 shows the detailed insider transactions of Valera Pharmaceuticals Inc since 2005. The reporting company's ticker symbol is VLRX. The reporting company's CIK number is 1305409.
The total value of stock buying since 2005 is $246,530.
The total value of stock sales since 2005 is $209,251.
The total value of stock option exercises since 2005 is $375,624.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Valera Pharmaceuticals Inc (VLRX).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2007-04 0 $0 0 $0 100,000 $300,000
2007-02 0 $0 25,208 $209,251 25,208 $75,624
2006-05 16,000 $138,530 0 $0 0 $0
2006-02 12,000 $108,000 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Valera Pharmaceuticals Inc insiders (VLRX)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-04-02 Tierney David S (President and CEO) Option Ex 100,000 3.00 300,000
2007-02-26 Huckel Hubert E Md (Director) Sale 25,208 8.30 209,251
2007-02-26 Huckel Hubert E Md (Director) Option Ex 25,208 3.00 75,624
2006-05-25 Silverman Howard (Director) Buy 5,000 7.90 39,500
2006-05-25 Tierney David S (President and CEO) Buy 1,000 7.73 7,730
2006-05-04 Silverman Howard (Director) Buy 10,000 9.13 91,300
2006-02-02 Drechsler Andrew T (Chief Financial Officer) Buy 1,600 9.00 14,400
2006-02-02 Perron Pete (VP, Sales) Buy 500 9.00 4,500
2006-02-02 Kuzma Petr F (VP, Research and Dev) Buy 1,100 9.00 9,900
2006-02-02 Tierney David S (President and CEO) Buy 5,500 9.00 49,500
2006-02-02 Huckel Hubert E Md (Director) Buy 3,300 9.00 29,700

Insider trading activities including stock purchases, stock sales, and option exercises of VLRX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Valera Pharmaceuticals Inc (symbol VLRX, CIK number 1305409) see the Securities and Exchange Commission (SEC) website.